Riboflavin-responsive trimethylaminuria in a patient with homocystinuria on betaine therapy
Acute gallbladder disease (cholecystitis)
One of the most promising adoptive cell transfer approaches is chimeric antigen receptor (CAR) T-cell therapy, where T cells are genetically engineered to express a synthetic receptor that recognizes specific tumor-associated antigens
Also identified was increased risk of abdominal pain, gastroesophageal reflux disease (GERD), gastritis, non-infectious gastroenteritis, gastroparesis, diverticulosis, diverticulitis, low blood pressure, fainting, sleep disturbances, headaches, arthritis and joint pain, tendinitis, and kidney problems (interstitial nephritis and nephrolithiasis), gallstone formation and gallbladder inflammation
I feel great and no more trying to find the right clothes to cover up my muffin top
That first-session freshness is something special